Skip to main content
. 2022 Apr 25;63(3):273–284. doi: 10.4111/icu.20210391

Table 2. Baseline characteristics of the seven included studies.

Study Design Participanta Age (y)a Aetiology Site Length (mm)a Intervention Duration of post-op IDC (d) Follow-up (mo)
Regmi et al. 2018 [18] RCT 27 28 37.2±1.6 36±1.7 Traumatic 26 (47.2), inflammatory 12 (21.9), others 17 (30.9) N/S 9.3±3.3 10.7±3.2 Catheter coated with triamcinolone for 6 months (weaning) 7 12
Ergün et al. 2015 [19] RCT 30 30 61.2 60.7 Iatrogenic 74 (82.2), idiopathic 16 (17.8) N/S N/S N/S Catheter coated with triamcinolone weekly for 6 weeks 3 24
Yeşil et al. 2013 [20] RCT 22 19 45.1±8.0 47±8.8 Urethral instrumentation 12 (29), trauma 3 (7), urinary infection 7 (17), idiopathic 19 (46) Bulbar 7.4±4.0 7.8±4.3 Catheter coated with triamcinolone for 2 weeks N/A 36
Tavakkoli Tabassi et al. 2011 [21] RCT 34 36 42.38 42 Trauma (17.64), catheter (16.17), infection (5.88), unknown/other (60.31) Bulbar, penile 8.07±1.40 8.4±1.38 Submucosal triamcinolone injection (5 cc) 3–5 8.68±5.36
Gücük et al. 2010 [22] RCT 15 15 31.2±8.3 35.2±7.9 Trauma 13 (28.9), infectious 5 (11.1), instrumentation 11 (24.4), unknown 16 (35.6) Bulbar 8.3±2.7 8.3±1.9 Catheter coated with triamcinolone nightly for 2 weeks 3 16.4±2.97
Mazdak et al. 2010 [23] RCT 23 22 37.1±20.9 34±19.9 Traumatic 21 (46.8), Inflammatory 7 (15.5), unknown 17 (37.8) Bulbar 9.5±1.7 8.8±2.3 Submucosal triamcinolone injection (40 mg) 5 13.7±5.4
Hosseini et al. 2008 [24] RCT 30 34 37.7±17.1 34.5±13.3 Urethral distraction 29 (45.6), straddle Injury 12 (18.4), catheter 10 (15.7), other 13 (20.3) N/S 8.5±4.0 9±3 Catheter coated with triamcinolone for 6 months (weaning) N/A 12

Values are presented as number only, mean±standard deviation or number (%).

IDC, indwelling foley catheter; RCT, randomised control trial; N/S, not specified; N/A, not applicable.

a:Intervention control.